Fostamatinib And Efgartigimod: Novel Agents In The Treatment Of Itp

Fostamatinib and efgartigimod: novel agents in the treatment of ITP

VJHemOnc – Video Journal of Hematology & HemOnc

Shifting the treatment landscape of ITP: novel agents and future outlooks

VJHemOnc – Video Journal of Hematology & HemOnc

Novel promising agents for the treatment of ITP

VJHemOnc – Video Journal of Hematology & HemOnc

Investigating the Use of Fostamatinib in ITP

Novel investigational drugs and promising therapies for immune thrombocytopenia

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP

Insights from ADVANCE IV study: efgartigimod increases platelet counts of patients with ITP

VJHemOnc – Video Journal of Hematology & HemOnc

Thrombopoietin receptor agonists in ITP: current status and future outlooks

VJHemOnc – Video Journal of Hematology & HemOnc

Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia...

Research To Practice

Avatrombopag: a novel oral therapy for the treatment of ITP

VJHemOnc – Video Journal of Hematology & HemOnc

ASH Highlights: Efgartigimod Safe and Effective in Treating Immune Thrombocytopenia (ITP)

Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses

ITP: novel treatments

International Academy for Clinical Hematology IACH

Current unmet needs in ITP: impaired quality of life & chronic disorders

VJHemOnc – Video Journal of Hematology & HemOnc

Latest updates in the management of immune thrombocytopenia

VJHemOnc – Video Journal of Hematology & HemOnc

Fostamatinib as Second-Line ITP Therapy

Unmet needs in immune thrombocytopenia

VJHemOnc – Video Journal of Hematology & HemOnc

Dr.Gobind Rai Garg discusses the topic - Fostamatinib

Dr. Gobind Rai Garg

Immune Thrombocytopenia (ITP) Treatment: Fostamatinib #immunethrombocytopenia #ITP #shorts

Extensive Medicine

Recent advances in the mechanism & treatment of Immune Thrmobocytopenia